Iterum Therapeutics plc (ITRMF) Tax Provisions (2017 - 2025)

Iterum Therapeutics has reported Tax Provisions for 9 years, with the latest figure at $132000.0 in Q3 2025.

• On a quarterly basis, Tax Provisions fell 2.94% year-over-year to $132000.0 in Q3 2025; TTM through Sep 2025 was -$3.0 million, a 39.09% increase from a year earlier, with the FY2024 full-year figure at -$3.1 million, up 35.02% from the prior year.
• Tax Provisions was $132000.0 for Q3 2025 at Iterum Therapeutics, up from $59000.0 in the prior quarter.
• The five-year high for Tax Provisions was $427000.0 in Q1 2022, with the low at -$11.9 million in Q4 2021.
• Average Tax Provisions over 5 years is -$1.3 million, with a median of $60000.0 recorded in 2021.
• The largest YoY upside for Tax Provisions was 611.67% in 2022 against a maximum downside of 261.93% in 2022.
• Over 5 years, Tax Provisions stood at -$11.9 million in 2021, then surged by 51.92% to -$5.7 million in 2022, then rose by 9.2% to -$5.2 million in 2023, then soared by 36.78% to -$3.3 million in 2024, then surged by 104.02% to $132000.0 in 2025.
• The last three Tax Provisions figures came in at $132000.0 (Q3 2025), $59000.0 (Q2 2025), and $60000.0 (Q1 2025), per Business Quant data.